Correspondence re: L. E. Damon et al., Plasma and Cerebrospinal Fluid Pharmacokinetics of 1-β-d-Arabinofuranosylcytosine and 1-β-d-Arabinofuranosyluracil following the Repeated Intravenous Administration of High- and Intermediate-Dose 1-β-d-Arabinofuranosylcytosine. Cancer Res., 51: 4141–4145, 1991.—Reply

Damon, Lloyd E.; Plunkett, William; Linker, Charles A.

Correspondence re: L. E. Damon et al., Plasma and Cerebrospinal Fluid Pharmacokinetics of 1-β-d-Arabinofuranosylcytosine and 1-β-d-Arabinofuranosyluracil following the Repeated Intravenous Administration of High- and Intermediate-Dose 1-β-d-Arabinofuranosylcytosine. Cancer Res., 51: 4141–4145, 1991.—Reply

Lloyd E. Damon, M.D.;

Lloyd E. Damon, M.D.

Cancer Research Institute University of California

San Francisco, California 94143

Search for other works by this author on:

This Site

PubMed

Google Scholar

William Plunkett, Ph.D.;

William Plunkett, Ph.D.

University of Texas M. D. Anderson Cancer Center Department of Medical Oncology

Houston, Texas 77030